Synaptotagmin-1 functions as a Ca 2+ sensor in neurotransmitter release and was proposed to act on both the synaptic vesicle and plasma membranes through interactions involving the Ca 2+ binding top loops of its C 2 domains and the Ca 2+ -independent bottom face of the C 2 B domain. However, the functional importance of the C 2 B domain bottom face is unclear. We now show that mutating two conserved arginine residues at the C 2 B domain bottom face practically abolishes synchronous release in hippocampal neurons. Reconstitution experiments reveal that Ca 2+ -synaptotagmin-1 can dramatically stimulate the rate of SNARE-dependent lipid mixing, and that the two-arginine mutation strongly impairs this activity. These results demonstrate that synaptotagmin-1 function depends crucially on the bottom face of the C 2 B domain and strongly support the notion that synaptotagmin-1 triggers membrane fusion and neurotransmitter release by bringing the vesicle and plasma membranes together, much like the SNAREs do but in a Ca 2+ -dependent manner.
The Ca 2+ -triggered release of neurotransmitters by synaptic vesicle exocytosis is an exquisitely regulated process, having a fast, synchronous component that emerges in less than 0.5 ms upon Ca 2+ influx and a slower, asynchronous component 1 . Extensive evidence has shown that the synaptic vesicle protein synaptotagmin-1 acts as a Ca 2+ sensor in synchronous release (reviewed in refs. [1] [2] [3] . Most of the cytoplasmic region of synaptotagmin-1 consists of two C 2 domains (the C 2 A and C 2 B domains), which adopt similar b-sandwich structures and bind three and two Ca 2+ ions, respectively, through loops at the top of the b-sandwich [4] [5] [6] [7] [8] (Fig. 1a) . These top loops also mediate Ca 2+ -dependent binding of both C 2 domains to phospholipids [8] [9] [10] [11] , and decreasing or increasing the apparent Ca 2+ affinity of synaptotagmin-1 through point mutations in the Ca 2+ binding loops leads to parallel changes in the Ca 2+ dependence of neurotransmitter release 12, 13 . In addition to establishing the Ca 2+ -sensing role of synaptotagmin-1 in release, these results showed that the Ca 2+ -dependent phospholipid binding activity of the C 2 domain top loops is key for this function. Synaptotagmin-1 also binds to the neuronal soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs), which have a key role in membrane fusion by forming tight SNARE complexes that bring the synaptic vesicle and plasma membranes together (reviewed in refs. [1] [2] [3] 14, 15) . Ca 2+ -dependent binding of synaptotagmin-1 to SNARE complexes and phospholipids can occur simultaneously 16, 17 , which probably helps to couple synaptotagmin-1 and SNARE function.
Many current models assume that synaptotagmin-1 triggers release through an action on the plasma membrane, for instance, assisting in membrane fusion by inducing tension 1, 3 and/or positive curvature 18 . However, these models do not explain the observation that disrupting Ca 2+ binding to the C 2 B domain impairs release much more strongly 19, 20 than disruption of the C 2 A domain Ca 2+ binding sites [21] [22] [23] . This preponderant role of the C 2 B domain in release could arise in part from a polybasic region at one side of the C 2 B domain b-sandwich (Fig. 1a) that is not shared by the C 2 A domain and has been implicated in multiple interactions, including those with the SNARE complex 17, 24 and phospholipid binding 25 . However, although the moderate impairment in release caused by mutations in this polybasic region supports its involvement in exocytosis 25, 26 , it does not provide a satisfactory explanation for the dramatic difference in the functional importance of Ca 2+ binding to the C 2 B domain versus the C 2 A domain.
Another potential reason for this drastic difference was provided by the observation that the C 2 B domain can induce clustering of liposomes in the presence of Ca 2+ , whereas the C 2 A domain does not share this activity 27 . This finding led to a fundamentally different hypothesis of synaptotagmin-1 function, which proposed that the C 2 B domain acts not only on the plasma membrane but also on the vesicle membrane, bringing the two membranes into close proximity in a similar way to SNARE complexes but in a Ca 2+ -dependent manner that confers the acute Ca 2+ sensitivity of synaptic membrane fusion. In this model, the Ca 2+ binding loops at the top of the C 2 B domain b-sandwich bind to one membrane, and the basic residues at the opposite, bottom face bind to the other membrane 17, 27 (Fig. 1a) . However, although the crucial role of the C 2 B domain Ca 2+ binding region in release is well established 19, 20 , the functional importance of the bottom face has not been investigated.
We now report that, during electrophysiological studies designed to screen for features at the C terminus of the C 2 B domain that modulate Ca 2+ -triggered release, we have identified two highly conserved arginine residues that protrude from the bottom face of the C 2 B domain (Arg398 and Arg399; Fig. 1a ,b) as key residues for synaptotagmin-1 function. Mutation of these arginines almost abolishes Ca 2+ -triggered fast neurotransmitter release in hippocampal neurons. Further biophysical analyses showed that, in the presence of synaptotagmin-1, Ca 2+ can induce a dramatic increase in the rate of lipid mixing between reconstituted SNARE proteoliposomes, and that mutating the two arginines strongly impairs this activity owing to disruption of C 2 B domain-membrane interactions. Our results demonstrate that the Ca 2+ -independent, bottom face of the synaptotagmin-1 C 2 B domain has a crucial function in neurotransmitter release, similar in importance to the key role of the Ca 2+ -dependent, top face. Moreover, our data strongly support the notion that synaptotagmin-1 acts on both the vesicle and plasma membranes by bringing them together in a Ca 2+ -dependent manner through the Janus-faced nature of the C 2 B domain.
RESULTS
The two C 2 B domain bottom arginines are crucial for release To test the functional importance of the bottom face of the synaptotagmin-1 C 2 B domain, we used a synaptotagmin-1 knockout-rescue approach in autaptic hippocampal glutamatergic neurons 13 . In response to a single action potential, the excitatory postsynaptic current (EPSC) amplitude and charge of synaptotagmin-1-knockout neurons are drastically reduced, whereas asynchronous release remains unaltered 28 (Fig. 2) . Lentiviral expression of wild-type synaptotagmin-1 in knockout neurons restored the diminished Ca 2+ -triggered synchronous release to that of wild-type neurons ( Fig. 2 and M.X. and C.R., unpublished data). We next tested the effects of mutating Arg398 and Arg399, the two exposed, highly conserved arginines at the bottom loop between helix HA and strand b8 of the C 2 B domain (Fig. 1) . For this purpose, we prepared single mutants where one arginine was replaced by glutamine (R398Q and R399Q) and a double mutant (R398Q R399Q), which preserves proper folding of the C 2 B domain 27 (see also below). Lentiviral expression of these mutants in synaptotagmin-1-knockout neurons led to comparable protein levels to those observed for wild-type synaptotagmin-1 ( Supplementary  Fig. 1 online) , and immunocytochemistry showed that these mutants are colocalized with the synaptic vesicle marker synaptophysin-1, indicating that they are properly targeted to synapses ( Supplementary  Fig. 2 online) . Notably, the R398Q R399Q mutation practically abolished the rescue activity of synaptotagmin-1. Knockout neurons rescued by this mutant showed diminished synchronous release, and the evoked EPSC amplitude, charge and release time course resembled those of synaptotagmin-1-knockout neurons (Fig. 2) . Both R398Q and R399Q single mutants strongly reduced the evoked EPSC amplitude and charge ( Fig. 2a-c ), but the release remained largely synchronous (Fig. 2a,d ). These results demonstrate the crucial importance of the bottom region of the C 2 B domain for synaptotagmin-1 function in fast neurotransmitter release. Synaptotagmin-1 has been implicated at multiple steps of the synaptic vesicle cycle. To pinpoint the function of the C 2 B domain bottom face, we directly assessed Ca 2+ -triggered release efficiency by measuring the vesicular release probability (P vr ), the fraction of fusion-competent vesicles released by an action potential. This parameter is assessed by the ratio of the single EPSC charge to the readily releasable vesicle pool (RRP) charge. We measured RRP from the synaptic responses induced by a 4-s application of hypertonic sucrose solution 29 and found no significant differences in RRP size among all the groups (P 4 0.05, data not shown). Consequently, mutating either or both arginines caused a more than 80% reduction of P vr as compared to the wild-type synaptotagmin-1 rescue (Fig. 3a) . Consistent with the P vr data, mutating the arginines altered the short-term plasticity of rescued knockout neurons. In response to five consecutive action potentials delivered at 50 Hz, knockout neurons rescued by wild-type synaptotagmin-1 showed synaptic depression, whereas the R398Q, R399Q and R398Q R399Q mutations all led to enhanced synaptic facilitation (Fig. 3b) . In contrast to knockout neurons, the R398Q R399Q-rescued neurons showed some synchronous release after two or three stimuli, indicating that elevation of intracellular Ca 2+ concentrations can slightly rescue the R398Q R399Q phenotype (Fig. 3b) .
We then studied the Ca 2+ dependence of transmitter release by measuring the amplitudes of the evoked synaptic responses as a function of the external Ca 2+ concentrations. Fitting the data with a standard Hill equation revealed a more than two-fold decrease in the apparent Ca 2+ sensitivity of release in knockout neurons rescued with single (R398Q or R399Q) or double (R398Q R399Q) arginine mutants as compared to knockout neurons rescued with wild-type synaptotagmin-1 (Fig. 3c) .
The two-arginine mutation impairs membrane interactions Our electrophysiological results demonstrate that the unique bottom face of the C 2 B domain has an essential role at the Ca 2+ -triggering step of exocytosis and support the proposal that binding of the C 2 B domain to the vesicle and plasma membranes through the bottom face and the Ca 2+ binding top loops is crucial for release. However, it is also plausible that the R398Q R399Q mutation at the bottom of the C 2 B domain might have allosteric effects that impair Ca 2+ binding. This possibility is unlikely because Ca 2+ binding to the C 2 B domain does not change the chemical shifts at the bottom face 8 . We ruled this out this possiblity by comparing 1 H-15 N HSQC spectra of the wildtype and R398Q R399Q mutant C 2 AB fragments, which showed that the mutation does not alter Ca 2+ binding and does not cause substantial structural alterations in the Ca 2+ binding loops or any other region of the C 2 AB fragment ( Supplementary Fig. 3 online) .
The R398Q R399Q mutation could also alter synaptotagmin-1-SNARE complex interactions. To test this possibility, we examined the ability of the C 2 AB fragment to displace a complexin-1 fragment from SNARE complexes anchored on supported phospholipid bilayers 30 , an activity that requires Ca 2+ -dependent phospholipid binding of the top loops of the C 2 AB fragment and interactions with SNARE complexes 17 . The R398Q R399Q mutation did not substantially change this activity (Fig. 4a) , showing that this mutation does not interfere with the interaction of the C 2 AB fragment with the SNARE complex.
On the basis of these results, the most likely explanation for our electrophysiological data is that the inhibition of release by the R398Q R399Q mutation arises from disruption of crucial membrane interactions of the bottom face of the C 2 B domain. The R398Q R399Q mutation abolishes the ability of the synaptotagmin-1 C 2 B domain to induce clustering of phospholipid vesicles in vitro 27 , showing that the bottom face can indeed participate in membrane interactions in vitro. However, the R398Q R399Q mutation did not seem to impair the ability of the C 2 AB fragment to cluster vesicles after a 10-min incubation in 1 mM Ca 2+ (ref. 27) . To test the effects of this mutation under more stringent conditions, we monitored the ability of different synaptotagmin-1 fragments to induce vesicle clustering as a function of time in the presence of 0.1 mM Ca 2+ using dynamic light scattering (DLS). The wild-type C 2 AB fragment quickly induced vesicle clustering, as manifested by the observed increase in the average particle size within the first few minutes, and C 2 AB fragments with mutations that disrupt Ca 2+ binding to the C 2 A domain (D178N 6 ) or the C 2 B domain (D309N 8 ) showed the same clustering activity (Fig. 4b) , as observed previously 27 . Also in agreement with previous results, the isolated C 2 B domain clustered vesicles efficiently, and this activity was abolished by the D309N and the R398Q R399Q mutations (Fig. 4b) . Notably, the R398Q R399Q mutation also impaired strongly the 
Numbers of neurons analyzed in a-c are indicated. ability of the C 2 AB fragment to cluster vesicles under these conditions; addition of 1 mM Ca 2+ after 500 s accelerated clustering by the R398Q R399Q C 2 AB fragment, leading to large clusters after 10 min, as observed previously 27 , but the kinetics of clustering was still slower in 1 mM Ca 2+ than for the wild-type C 2 AB fragment in 0.1 mM Ca 2+ (Fig. 4b) . Hence, the bottom face of the C 2 B domain is more crucial for vesicle clustering than Ca 2+ binding to either the C 2 A or C 2 B domains. However, clustering does require Ca 2+ binding to at least one C 2 domain, as a double D178N D309N mutation in the C 2 AB fragment completely abolished its clustering activity ( Supplementary  Fig. 4 online).
Fast stimulation of lipid mixing by Ca 2+ -synaptotagmin-1 To further investigate the minimal requirements for the role of the R398Q R399Q mutation with a defined reductionist system, we turned to reconstitution experiments with SNARE-containing proteoliposomes, in which the ability of protein components to induce lipid mixing is used as an indication of their potential roles in membrane fusion 31 . Early studies using a standard fluorescence-dequenching assay 31 showed that the Ca 2+ -bound synaptotagmin-1 C 2 AB fragment can increase the rate of SNARE-dependent lipid mixing 32 . For our studies, we adopted an approach whereby SNARE complex assembly is facilitated by pre-incubation of the t-SNARE liposomes with a peptide containing the C-terminal half of the synaptobrevin SNARE motif 33 . Incubation of equal amounts of target (t)-SNARE and vesicle (v)-SNARE liposomes containing 1:200 protein-to-lipid (P:L) ratios led to efficient and saturable lipid mixing ( Supplementary Fig. 5a online), as described 33 . Conversion of the observed fluorescence dequenching to rounds of liposome fusion 34 showed that saturation occurs at 1.16 rounds of fusion ( Supplementary Fig. 5b ), which suggests that fusion is quantitative under these conditions and corresponds to an increase in relative fluorescence with respect to the initial value (F/F 0 ) of 1.52. Because, in our hands, representation of lipid mixing assays using F/F 0 , as adopted in previous work 33 , yields more consistent results than conversion to rounds of fusion (probably because of variability in the maximum fluorescence observed upon detergent addition, which is used for this conversion), we used the former method to express the lipid-mixing data described below (Fig. 5) .
As described previously 35 , Ca 2+ plus the C 2 AB fragment did not enhance lipid mixing at 1:200 P:L ratio (Fig. 5a) . As the absence of a stimulating effect of Ca 2+ -synaptotagmin-1 is likely to arise because the SNAREs are too active at this P:L ratio, in all subsequent experiments, we lowered the P:L ratio to 1:500, which markedly decreased the lipid-mixing efficiency of the SNAREs alone (Fig. 5a) . Inclusion of 1 mM C 2 AB fragment in the initial reaction under these conditions did not substantially alter the lipid-mixing rate; however, notably, addition of 0.1 mM Ca 2+ after 250 s led to a dramatic increase in lipid mixing (Fig. 5b) . This effect was SNARE dependent, as it was inhibited by the soluble region of synaptobrevin, and the C 2 AB fragment did not induce lipid mixing in the absence of SNAREs ( Supplementary Fig. 6 online) . The lipid-mixing stimulation required the C 2 AB fragment and was specific for Ca 2+ because 1 mM Ca 2+ without the C 2 AB fragment or 1 mM Mg 2+ in the presence of the C 2 AB fragment had no effect (Fig. 5b) . In multiple experiments (for example, black traces in Fig. 5b ,c,f), lipid mixing was saturated at values of F/F 0 above 1.5, which corresponds to at least one round of fusion and thus suggests that fusion is quantitative (see above). Although there was some variability in the lipid-mixing rates, we consistently observed strong increases in these rates (40-fold to 130-fold) upon Ca 2+ addition in the presence of the C 2 AB fragment. Conversion to rounds of fusion 34 and curve fitting yielded a rate of 0.099 ± 0.035 rounds of fusion per second during the initial burst upon Ca 2+ addition (corresponding to a time constant t of around 10 s).
The two-arginine mutation impairs lipid-mixing stimulation We next examined the effects of different mutations on the lipidmixing enhancement caused by the Ca 2+ -bound C 2 AB fragment (Fig. 5) . Quantification of stimulation activities was hindered by variability in the background lipid mixing occurring before Ca 2+ addition and occasional downward baseline drifts after Ca 2+ addition, which may arise in part from sample precipitation (for example, Fig. 5h ). However, we obtained consistent estimates of the relative activities of the different synaptotagmin-1 fragments by measuring the increase in F/F 0 40 s after Ca 2+ addition (after subtracting the background of Ca 2+ -independent lipid mixing) and normalizing the data to the F/F 0 increase measured for the wild-type C 2 AB fragment with the same proteoliposome preparations (Fig. 6) . Notably, the R398Q R399Q mutation in the bottom of the C 2 B domain strongly impaired the ability of the C 2 AB fragment to stimulate lipid mixing Figure 4 The R398Q R399Q mutation impairs synaptotagmin-1-membrane interactions. (a) The R398Q R399Q mutation does not impair the ability of the C 2 AB fragment to displace a complexin-1 fragment from membrane-anchored SNARE complexes. Supported phospholipid bilayers containing reconstituted SNARE complexes were deposited into microchannels, a rat complexin-1 fragment (residues 26-83) labeled with BODIPY-FL was bound to the SNARE complexes, and displacement of the labeled complexin-1 fragment by increasing concentrations of C 2 AB fragment (black circles) or C 2 AB-R398Q R399Q fragment (red circles) was monitored with a confocal fluorescence microscope as described 17, 30 . The data were normalized to the background fluorescence. Error bars represent s.e.m. derived from three separate measurements. Fitting of the data to a dose-response curved yielded an effector concentration for half-maximum response (EC 50 ) of 12 nM for both the wild-type and mutant C 2 AB fragment, which is comparable to earlier results obtained for the wild-type C 2 AB fragment 30 . (b) The R398Q R399Q mutation impairs the vesicle clustering activity of the C 2 AB fragment. Mixtures of liposomes (100 nm average size) with the wild-type or mutant C 2 B domain or the C 2 AB fragment were prepared as described 27 , and the change in particle size as a function of time was measured by DLS after addition of 100 mM Ca 2+ . For the experiment performed with the R398Q R399Q mutant C 2 AB fragment, 1 mM Ca 2+ was added after 500 s. (Fig. 5d) . The single R398Q and R399Q mutations also led to marked impairments of the lipid mixing, although to a lesser extent (Figs. 5c and 6 ). For comparison, we also tested the effects of mutations that disrupt Ca 2+ binding to the C 2 A or C 2 B domains (D178N and D309N, respectively). Both mutations impaired lipid-mixing stimulation but less strongly than the double R398Q R399Q mutation (Figs. 5e and 6) . Although the effects of the single arginine mutations on lipidmixing stimulation correlate qualitatively with their inhibitory effects on neurotransmitter release (Fig. 2) , the latter were much stronger. Moreover, the stronger impairment of lipid-mixing activity caused by the D178N mutation in the C 2 A domain, compared to the D309N mutation in the C 2 B domain, contrasts with the preponderant role of the C 2 B domain in release [19] [20] [21] [22] [23] . This discrepancy was observed previously 35 and may arise because the C 2 AB fragment probably binds to two apposed membranes in diverse orientations 27 . Notably, we found that the isolated C 2 B domain can partially support the Ca 2+ -induced lipid-mixing enhancement, whereas the isolated C 2 A domain does not share this ability (Figs. 5f and 6 ). Note that previous data suggesting that the C 2 B domain cannot increase SNARE-mediated lipid mixing 32 may arise from known difficulties in purifying the C 2 B domain 36 , and, indeed, we did not observe lipid-mixing stimulation when we used C 2 B domain purified under less stringent conditions (Fig. 5f) . The ability of properly purified C 2 B domain to support the lipid-mixing enhancement was abrogated by both the R398Q R399Q mutation and the D309N mutation, which disrupts Ca 2+ binding to the C 2 B domain (Figs. 5g and 6) . Even the single R398Q and R399Q mutations strongly impaired lipid-mixing stimulation by the C 2 B domain (Figs. 5h and 6) , showing that both arginines cooperate in this activity, as they do in neurotransmitter release. Thus, our data with the isolated C 2 domains correlate with the preponderant role of Wild-type and mutant C 2 B domains were purified using our standard protocol 36 , except for one experiment where the wild-type C 2 B domain was purified under less stringent conditions (indicated as C 2 B* (blue triangles) in f). Each set of experiments shown in each panel was performed on the same day with the same proteoliposome preparations. Figure 6 Relative fusion-stimulation activities of synaptotagmin-1 fragments. Lipid mixing assays analogous to those shown in Figure 5 were performed for each synaptotagmin-1 fragment. 
DISCUSSION
Synaptotagmin-1 function is generally assumed to involve an action of the Ca 2+ binding top loops of its C 2 domains on the plasma membrane 1, 3, 18 . Through electrophysiological screens for additional functional sites on the C2B domain, we have now found that two arginine residues located at its bottom face are crucial for the function of synaptotagmin-1 in neurotransmitter release. These residues are also key to its ability to bring two membranes together and to stimulate SNARE-mediated lipid mixing in vitro. These results show that synaptotagmin-1 function depends not only on the Ca 2+ binding loops but also on the C 2 B domain bottom face, and they strongly support the notion that synaptotagmin-1 cooperates with the SNARE complex in triggering fast membrane fusion by binding simultaneously to the vesicle and plasma membranes (Fig. 7) .
The almost complete abrogation of fast release caused by the double R398Q R399Q mutation (Fig. 2) is notable. Although the functional effects of many point mutations in synaptotagmin-1 have been studied [1] [2] [3] , only mutations in the C 2 B domain Ca 2+ binding sites lead to a comparably strong impairment of release as assessed with highly sensitive electrophysiological recordings in mammalian synapses 20 . Even single mutation of either of these arginines results in a strong inhibition of release (Fig. 2) , suggesting that both arginines cooperate in a critical activity. Mutation of both sites does not completely block synaptotagmin-1 function; notably, the R398,R399 double mutant mimicked the synaptotagmin-1-knockout phenotype at low-frequency stimulation, yet this mutant was still weakly active in triggering release, as high-frequency stimulation slightly restored synchronous release, presumably owing to residual activity of the bottom face of the C 2 B domain.
The key role of this bottom face in release is unlikely to involve direct interactions of Arg398 and Arg399 with the SNARE complex because the R398Q R399Q mutation did not impair the ability of the C 2 AB fragment to displace a complexin-1 fragment from membraneanchored SNARE complexes (Fig. 4a) . This observation agrees well with the notion that the Ca 2+ binding loops and the bottom face of the C 2 B domain bind to two apposed membranes, leaving the polybasic region of the C 2 B domain available for binding to SNARE complexes 17 (Fig. 7) . Moreover, NBD fluorescence experiments showed that the C 2 B domain bottom face interacts with membranes 27 , and the profound impairment of vesicle clustering activity caused by the R398Q R399Q mutation (Fig. 4b) demonstrates that interactions of Arg398 and Arg399 with lipids are crucial for the ability of synaptotagmin-1 to bring two membranes together. These findings, together with our lipid-mixing assays, strongly suggest that the impairment of neurotransmitter release caused by the R398Q R399Q mutation is due to disruption of crucial C 2 B domainmembrane interactions.
Lipid-mixing assays must be interpreted with caution because they do not necessarily reflect physiological membrane-fusion events 2 . Thus, the relevance of initial data showing that the Ca 2+ -bound synaptotagmin-1 C 2 AB fragment enhances SNARE-dependent lipid mixing 32 was unclear, as the enhancement was modest (two-fold to four-fold), the lipid-mixing rates were slow (t 4 30 min 32 ) and the effects of Ca 2+ binding site mutations on lipid-mixing stimulation did not correlate well with their effects on release 35, 37 . Our data show that, in the presence of 1 mM C 2 AB fragment and under our experimental conditions, 100 mM Ca 2+ can induce a much more dramatic stimulation of lipid mixing (B100-fold) and lead to much faster lipid-mixing rates (t B10 s), results that are noteworthy considering the limitations of these bulk lipid-mixing assays and the mild conditions of our experiments. These observations strongly support the notion that synaptotagmin-1 has a direct role in enabling fast Ca 2+ -triggered membrane fusion during release. Another study recently showed that pre-incubation with the C 2 AB fragment allows a strong Ca 2+ -dependent stimulation of SNARE-dependent lipid mixing, which is further enhanced by a synaptobrevin C-terminal peptide 38 ; although the maximum lipid-mixing rates reported (t B43 s at 1 mM Ca 2+ and 20 mM C 2 AB fragment) were not as fast as those described here, these data probably reflect the same fundamental property of synaptotagmin-1 that underlies our results and also support its proposed role in Ca 2+ -triggered fusion.
Plasma membrane Synaptic vesicle Figure 7 Proposed mode of how the synaptotagmin-1 C 2 B domain and the SNARE complex cooperate in Ca 2+ -triggered membrane fusion. The C 2 B domain is colored in blue, syntaxin in yellow, SNAP-25 in green and synaptobrevin in pink. The C 2 A domain (not shown for simplicity) is predicted to help in release by binding to one of the membranes, but it could have additional roles that remain to be demonstrated. The model predicts that the Ca 2+ binding loops at the top of the C 2 B domain bind to one membrane, the bottom face to the other membrane, and the polybasic region to the SNARE complex (see Fig. 1a for the locations of these structural elements in the C 2 B domain structure). In principle, the Ca 2+ binding loops could act either on the vesicle or the plasma membrane. + shows the abundance of positive charges in the C 2 B domain and the C terminus of the SNARE complex 17 . The red arrows in the top diagram indicate that these positive charges are likely to help to attract the lipids toward the center, inducing negative curvature on the membranes to initiate fusion.
As observed in earlier reconstitutions 35, 37 , our experiments with the C 2 AB fragment do not reproduce the relative importance of the C 2 domain Ca 2+ binding sites observed in vivo (Figs. 5e and 6 ). This discrepancy may arise because the C 2 AB fragment may support lipidmixing stimulation by binding to two apposed membranes with diverse relative orientations of the two C 2 domains, some of which may be irrelevant in vivo (note that single Ca 2+ binding site mutations do not prevent vesicle clustering by the C 2 AB fragment; Fig. 4b ). Despite this caveat, it seems highly unlikely that the lipid-mixing stimulation caused by Ca 2+ in the presence of the C 2 AB fragment arises from completely irrelevant interactions. First, the strong impairment of the C 2 AB fragment activity in the lipid-mixing assays caused by the R398Q R399Q mutation (Fig. 5c) shows that this activity depends on some specific interactions and clearly correlates with the disruption of release caused by this mutation (Figs. 2 and 3) . Second, the isolated C 2 B domain, but not the C 2 A domain, can support fast Ca 2+ -induced lipid mixing (Fig. 5f ), in agreement with the preponderant role of the C 2 B domain for release [19] [20] [21] [22] [23] . Third, lipid-mixing stimulation is abrogated by both the R398Q R399Q mutation and the D309N mutation that disrupts Ca 2+ binding when the C 2 B domain is used (Fig. 5g) , in correlation with the effects of these mutations in vivo 19, 20 (Fig. 2) . These observations suggest that our reconstitutions reproduce at least in part the events that lead to Ca 2+ -triggered neurotransmitter release in vivo.
It is noteworthy that these results were obtained with soluble synaptotagmin-1 fragments, whereas reconstitutions with full-length synaptotagmin-1 have been more difficult owing to undesired 'cis' interactions with the v-SNARE membrane 35 and a tendency of the full-length protein to aggregate 38 . It is plausible that the proper behavior of full-length synaptotagmin-1 may require additional factors present in vivo, whereas the essence of the function of its C 2 domains can be captured more easily in these in vitro assays with the soluble C 2 AB fragment, probably because their function is mostly associated to interactions with Ca 2+ , phospholipids and the SNAREs. Note in this context that some synaptotagmin isoforms are localized to vesicles and others to the plasma membrane 1 , and that the synaptotagmin C 2 domains are connected to their transmembrane regions by long linkers, which may allow similar mechanisms of action for the C 2 domains regardless of the membrane localization.
The finding that the Ca 2+ -independent bottom face of the C 2 B domain is so crucial for the Ca 2+ -dependent function of synaptotagmin-1 may seem paradoxical but can be easily explained by the overall cooperativity of the system. For instance, the bottom face of one C 2 B domain molecule is insufficient for lipid binding in the absence of Ca 2+ , but its key role in Ca 2+ -induced vesicle clustering can be explained because accumulation of multiple C 2 B domains on one membrane upon Ca 2+ -dependent binding through its top loops allows cooperation of their bottom faces in binding to a second, closely apposed membrane 27 . Similar mechanisms, enhanced by specific interactions with SNARE complexes 16, 17, 39 , are likely to underlie the key role of the C 2 B domain bottom face for lipid mixing in vitro and neurotransmitter release in vivo. The fact that synaptotagmin-1 can bring two membranes together, in a similar way to SNAREs, but in a Ca 2+ -dependent manner, and that the top and bottom surfaces of the C 2 B domain involved in this activity are both crucial for neurotransmitter release, strongly support the notion that binding of these surfaces to the apposed vesicle and plasma membranes is fundamental for the action of synaptotagmin-1 in membrane fusion and Ca 2+ triggering of release (Fig. 7) . These observations suggest an attractive mechanism for the exquisite Ca 2+ dependence of release whereby assembly of the C terminus of the neuronal SNARE complex may not provide sufficient energy to bring the two membranes close enough to induce fusion 40 , and whereby fusion requires cooperation with the Ca 2+ -dependent activity of synaptotagmin-1 in binding to the two membranes (note that the Ca 2+ sensitivity of release may also involve inhibition by synaptotagmin-1 and complexins before Ca 2+ influx 27, 30, 38, [41] [42] [43] [44] ). Moreover, the highly positive electrostatic potential provided by the C 2 B domain and the SNARE complex C terminus may help to induce negative curvature on the membranes to accelerate fusion 17, 27 , a notion supported by theoretical calculations 45 .
Conversely, a recent study concluded that synaptotagmin-1 causes fusion by inducing positive membrane curvature through the Ca 2+ binding loops of both C 2 domains 18 . However, the experimental basis for this model arises from liposome-tubulation assays performed in high concentrations of uranyl acetate, an agent that strongly perturbs membranes 46, 47 , and the C 2 AB fragment induces little tubulation in the absence of this agent 27 . Moreover, this model does not provide an explanation for the preponderant role of the C 2 B domain and predicts that the C 2 domain Ca 2+ binding loops are oriented toward the fusion pore, whereas the bottom face of the C 2 B domain is facing away from the site of fusion ( Supplementary Fig. 7a online) , which makes it difficult to envisage how the R398Q R399Q mutation could lead to strong impairment of neurotransmitter release and membrane fusion. Note, however, that that this model is not completely incompatible with the model of Figure 7 because bending of the membranes to initiate membrane fusion requires both negative and positive curvature ( Supplementary Fig. 7b) .
Regardless of the validity of these models, our data together with previous studies 19, 20 conclusively demonstrate that synaptotagmin-1 function depends critically on both the Ca 2+ binding top loops and the Ca 2+ -independent bottom face of the C 2 B domain, and they suggest that this Janus-faced nature is crucial for triggering membrane fusion at the high speeds required for synchronous neurotransmitter release. It is noteworthy that distinct functions have also been proposed for the top and bottom faces of the rabphilin C 2 B domain 48, 49 , suggesting that the ability to interact with apposed targets may be a general property of a subset of C 2 domains.
METHODS
Animals and cell culture. We obtained synaptotagmin-1 heterozygous mice from T. Südhof (Stanford University) 28 and generated synaptotagmin-1 knockout mice by interbreeding the heterozygous mice. All procedures for maintenance and use of these mice were approved by the Institutional Animal Care and Use Committee for Baylor College of Medicine and Affiliates. Astrocytes and hippocampal neurons from postnatal day 0 (P0) mice were cultured as described 50 . Neurons were plated at a density of 300 cm -2 on microisland astrocyte feeder layers for autaptic electrophysiology and immunocytochemistry. For western blot analyses of protein expression, we plated neurons at a density of 10,000 cm -2 on confluent astrocyte feeder layers.
Lentivirus constructs and production. We used a modified lentiviral vector 51 containing a human synapsin-1 promoter and a ubiquitin C promoter to drive the expression of mouse synaptotagmin-1 and enhanced green fluorescent protein (EGFP), respectively. Standard recombinant DNA techniques were used to generate all synaptotagmin-1 mutations. We produced lentiviruses as described 51 and used them to infect neurons within 24 h of the cells being plated.
Western blotting and immunocytochemistry. We extracted proteins from cultured neurons and astrocytes as described 50 . Expression levels of wild-type and mutant synaptotagmin-1 variants were examined by standard SDS-PAGE and western blotting. The presynaptic targeting of wild-type and mutant synaptotagmin-1 variants were examined by immunocytochemistry and confocal microscopy. Neurons were imaged with a 63Â oil objective on a Zeiss 510 laser-scanning confocal microscope. Images were acquired as z-stacks and processed using the US National Institutes of Health ImageJ (http:// rsbweb.nih.gov/ij/) to create sum projections from the stacks. The primary antibodies (all from Synaptic Systems) were mouse anti-b-tubulin III (clone 3B11, 1:4000 for western blotting), mouse anti-synaptotagmin-1 (clone 41.1, 1:10,000 for western blotting and 1:100 for immunocytochemistry) and rabbit anti-synaptophysin-1 (1:1000 for immunocytochemistry).
Electrophysiology of autaptic hippocampal neurons. Whole-cell voltageclamp recordings were performed on approximately equal numbers of neurons from every group in parallel on the same day in vitro (day 8-12 in vitro) as described 50 with modifications. Briefly, the patch pipette solution contained 136 mM KCl, 17.8 mM HEPES, 1 mM EGTA, 0.6 mM MgCl 2 , 4 mM ATP-Mg, 0.3 Mm GTP-Na, 12 mM phosphocreatine and 50 U ml -1 phosphocreatine kinase (300 mOsm, pH 7.4). The standard external solution contained 140 mM NaCl, 2.4 mM KCl, 10 mM HEPES, 10 mM glucose, 2 mM CaCl 2 , 4 mM MgCl 2 (300 mOsm, pH 7.4). For the apparent Ca 2+ sensitivity of release experiments, the external solution contained 1 mM Mg 2+ and various Ca 2+ concentrations as indicated. Each test measurement was preceded and followed by a measurement in standard external solution to control for the rundown of synaptic responses. The amplitudes of EPSCs at each Ca 2+ concentration were normalized to the amplitudes in standard external solution. All data were then normalized to the maximal value (the response in 12 mM Ca 2+ ). Data were fitted with a standard Hill equation:
where Y is the response amplitudes, X is the Ca 2+ concentration, M is the maximum response amplitude, K d is the dissociation constant and n is the Hill coefficient. All experiments were performed at room temperature (23-24 1C) . Data were analyzed offline using AxoGraph X 1.0 (AxoGraph Scientific) and KaleidaGraph (Synergy Software). Statistical significance was tested using the Student's t-test, one-way analysis of variance or two-way analysis of variance.
Protein expression and purification. Full-length rat synaptobrevin-2 or a fragment spanning residues 49-96, full-length human SNAP-25A (with its four cysteines mutated to serines), a rat syntaxin-1A fragment spanning its SNARE motif and transmembrane region (residues 183-288), a rat complexin-1 V61C mutant fragment (residues 26-83), and wild-type or mutant rat synaptotagmin-1 fragments (C 2 A domain, residues 140-267; C 2 B domain, residues 271-421; C 2 AB fragment, residues 140-421) were expressed in Escherichia coli and purified as described 6, 8, 27, 30, 33, 36, 52 , except for one sample of the wild-type C 2 B domain, which was purified by gel filtration on a Superdex 75 column (GE Health Sciences) in PBS (experiment labeled C 2 B* in Fig. 5f ) instead of our standard procedure 36 . The D178N, D309N and R398Q R399Q mutants of the C 2 B domain and C 2 AB fragment were described previously 27 , and expression vectors for the single R398Q and R399Q mutants, as well as the D178N D309N double mutant, were made using standard recombinant DNA techniques.
Lipid-mixing assays. Proteoliposomes containing either synaptobrevin-2 (v-SNARE) or SNAP-25A (with its four cysteines mutated to serines) and syntaxin-1A 183-288 (t-SNARE) were reconstituted as described 33 except that the P/L ratio was 1:500 unless otherwise indicated. v-SNARE liposomes contained a 5:2:1:1:1 mixture of phosphatidylcholine, phosphatidylethanolamine (PE), phosphatidylserine, phosphatidylinositol and cholesterol. t-SNARE liposomes contained the same lipid mixture but replacing 20% PE with 17% PE, 1.5% N-NBD-1,2-dipalmitoyl PE and 1.5% N-(lissamine rhodamine B sulfonyl)-1,2-dipalmitoyl PE) (all lipid ratios expressed in moles). Briefly, dried lipid mixtures were resuspended in 20 mM HEPES, pH 7.4, 100 mM KCl, 5 mM DTT, 5% (w/v) sodium cholate (13.5 mM total lipid). SNARE proteins solubilized in 20 mM sodium cholate were added in the desired ratio and the mixture was passed through a Fast Desalting PC 3.2/10 column (GE Healthcare) in 20 mM HEPES, pH 7.4, 150 mM KCl, 1 mM DTT. Lipid and protein recoveries in the resulting proteoliposomes were practically quantitative, as the central 1 ml fraction collected from the size-exclusion column contained 75-95% of the starting materials based on the lipid absorption at 574 nm and comparison with standard protein samples of know concentration using Coomassie Blue-stained SDS-PAGE gels (see Supplementary Fig. 8 online for a gel of representative proteoliposomes). For lipid-mixing assays, v-SNARE and t-SNARE liposomes (the latter mixed with an equimolar amount of synaptobrevin ) were separately incubated for 1 h at 37 1C and then mixed at 37 1C in 20 mM HEPES, pH 7.4, 150 mM KCl, 1 mM DTT (0.4 ml final volume; 500 nM final protein concentration). NBD fluorescence emission at 538 nm (excitation 460 nm) was monitored with a PTI spectrofluorimeter. Synaptotagmin-1 fragments (1 mM final concentration) were added at the beginning of the reaction and divalent cations were added after 250 s.
Miscellaneous procedures. Complexin-displacement assays were performed in 25 mM HEPES, pH7.4, 100 mM KCl, 0.1 mM EGTA, 0.3mM Tris-(2-carboxyethyl)phosphine (TCEP), 1 mM Ca 2+ as described 17, 30 . Briefly, supported bilayers containing assembled SNARE complexes deposited within single microfluidic channels were incubated with 50 nM BODIPY-FL-labeled V61C-complexin 1 for 15 min, and unbound complexin was washed out. Unlabeled wild-type or R398Q R399Q mutant C 2 AB fragment at the desired concentration was added and incubated for 10 min, followed by a wash with buffer. BODIPY-FL fluorescence was measured with a Leica (Wetzlar) confocal microscope (TCS SP2) and quantified with Image J. Average fluorescence intensities measured under each condition were normalized to a control where the complexin-1 fragment was added to plain supported bilayers 17 .
Vesicle-clustering assays were performed basically as described 27 but with modifications. Briefly, 100 nm liposomes prepared by extrusion (dioleoylphosphatidylserine (DOPS)/ 1-palmitoyl-2-oleoylphosphatidylcholine (POPC) 30:70) were mixed with the corresponding synaptotagmin-1 fragment in 40 mM HEPES, pH 7.5, 100 mM NaCl (0.05 mg ml -1 lipids; 0.5 mM protein), and particle size as a function of time after addition of 100 mM Ca 2+ was measured by DLS using a Protein Solutions DynaPro instrument.
Note: Supplementary information is available on the Nature Structural & Molecular Biology website.
